Ravi K. Gupta/LinkedIn
Jun 6, 2025, 08:20
Ravi K. Gupta: Honored to Learn from Dr. Margaret Gatti-Mays at ASCO 2025 on Advancements in Breast Cancer Care
Ravi K. Gupta, Hematology-Oncology Fellow at Larkin Health System, shared a post on LinkedIn:
“Thank you, Dr. Margaret Gatti-Mays, for your time, insights, and invaluable guidance during our conversation at the ASCO 2025 Annual Meeting. It was an honor to speak with a leader who is transforming the landscape of breast cancer care through innovation, research, and patient advocacy.
As Chief of Breast Medical Oncology at OSUCCC – James, Dr. Gatti-Mays is pioneering next-generation therapies—from developing the first-in-human NK cell–based immunotherapy for metastatic breast cancer to refining chemoimmunotherapy protocols in early-stage TNBC based on KEYNOTE-522 data.
Her dedication to advancing treatment for rare subtypes like small-cell breast cancer, managing immune-related adverse events, and shaping equitable immunotherapy guidelines through her leadership at SITC reflects a rare blend of scientific rigor and human-centered care.
“Yesterday’s clinical trials are tomorrow’s treatments.” That mindset drives real change—and it’s clear Dr. Gatti-Mays is leading the way. Grateful for the opportunity to learn from her and to share her vision with our audience.”
Read OncoDaily’s Special Articles about ASCO 2025:
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 7, 2025, 14:53
Jun 7, 2025, 14:10
Jun 7, 2025, 12:23